DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 129 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,292,715 | -72.1% | 87,523 | -80.3% | 0.00% | -70.0% |
| Q3 2022 | $4,636,000 | -50.6% | 444,132 | -48.7% | 0.01% | -44.4% |
| Q1 2022 | $9,389,000 | -21.7% | 866,332 | +1.7% | 0.02% | -18.2% |
| Q4 2021 | $11,985,000 | -87.8% | 851,895 | -83.4% | 0.02% | -94.6% |
| Q3 2021 | $98,295,000 | +2785.1% | 5,116,856 | +1376.4% | 0.41% | +2450.0% |
| Q1 2021 | $3,407,000 | +1319.6% | 346,586 | +953.5% | 0.02% | +1500.0% |
| Q1 2019 | $240,000 | +421.7% | 32,898 | +549.9% | 0.00% | – |
| Q4 2018 | $46,000 | -97.6% | 5,062 | -96.8% | 0.00% | -100.0% |
| Q3 2018 | $1,948,000 | +109.7% | 157,172 | +225.5% | 0.01% | -11.1% |
| Q1 2016 | $929,000 | +288.7% | 48,285 | +396.4% | 0.01% | +200.0% |
| Q3 2015 | $239,000 | -80.5% | 9,727 | -81.4% | 0.00% | -81.2% |
| Q2 2015 | $1,227,000 | – | 52,377 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |